Pityriasis rosea-like drug eruption due to bupropion: a case report.
Pityriasis rosea (PR) is a common, acute, and self-limited inflammatory skin disease. The typical clinical presentation includes the appearance of a primary "herald" patch followed within days to weeks by the onset of secondary scaly skin eruptions distributed along the skin tension line in most cases. Although PR is a well-known and relatively common disease, its cause is still not completely understood. However, viral agents, autoimmunity, psychogenic status, and numerous drugs have been proposed as possible factors to PR. Bupropion is known to cause hypersensitivity reactions. We present a clinical case of PR eruption caused by the use of bupropion. To the best of our knowledge, this is the first published case of PR associated with bupropion use.
Department of Dermatology, Medical Faculty, Abant Izzet Baysal University, Bolu, Turkey polatmualla@gmail.com.
M
M
Polat
Department of Pharmacology, Medical Faculty, Abant Izzet Baysal University, Bolu, Turkey.
Ö
Ö
Uzun
Department of Dermatology, Medical Faculty, Abant Izzet Baysal University, Bolu, Turkey.
I
I
Örs
Department of Pathology, Medical Faculty, Abant Izzet Baysal University, Bolu, Turkey.
Ç
Ç
Boran
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D016642:Bupropion / Q000009:adverse effects*; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017515:Pityriasis Rosea / Q000139:chemically induced*; D016540:Smoking Cessation
D018687:Antidepressive Agents, Second-Generation; D018765:Dopamine Uptake Inhibitors; D016642:Bupropion
Pityriasis rosea; bupropion; drug eruption